About Chr. Hansen
Chr. Hansen is a publicly listed company based in Copenhagen (Denmark) founded in 1843, and was acquired by PAI Partners in May 2005. Developer of natural solutions for the food, nutritional, pharmaceutical and agricultural industries. The company has 122 employees. Chr. Hansen has completed 8 acquisitions, including ASTARTE Probiotics, Bovamine and GangaGen. Its website chr-hansen.com draws about 13 thousand monthly visits. Its Indian entity Chr.Hansen (India) Private Limited reported revenue of ₹158 Cr. Its focus areas include Food and Agriculture, Food Processing, Food Ingredients and Speciality Ingredients.
Company details
Developer of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. They develop products based on microbial strains. The food cultures enzymes division provides products such as cheese, meat, and plant fermented bases. Its Health and Nutrition division provides probiotic cultures for dietary supplements, over-the-counter pharmaceuticals, infant formula, animal feed, and plant protection industries. The companys Natural Colors division offers natural color solutions for the food industries, including the beverage, confectionery, ice cream, dairy, fruit preparation, and prepared food segments
- Headquarters Copenhagen, Denmark
- Employees 122
- Stage Public
- SectorsConsumer
- Website chr-hansen.com/en
- Social LinkedIn X
- Acquired by PAI Partners (May 2005)
- Legal Name Chr.Hansen (India) Private Limited
- Date of Incorporation 16 Jan, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹158 Cr
FY 2025 · +22% YoY
- Indian entity net profit₹6.80 Cr
FY 2025 · 4% margin
- Indian entity EBITDA₹11.88 Cr
FY 2025 · 8% margin
- Latest Funding Round$193.08K (USD), Post-IPO
Nov 2022
- InvestorsEuropean Investment Bank
& 4 more
- Employee Count122
- Investments & AcquisitionsASTARTE Probiotics
& 7 more
- Acquired byPAI Partners
(May 2005)
Associated legal entities of Chr. Hansen
Chr. Hansen operates through Chr.Hansen (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Chr.Hansen (India) Private Limited CIN U15100MH2004PTC144042 | Active | 16 Jan 2004 | Mumbai, Maharashtra | ₹158 Cr | 2 | View details |
Funding Insights of Chr. Hansen
- Total Rounds 16
- Last Round Post-IPO — $193,081
- Investors Count 4
Latest 10 of 16 funding rounds of Chr. Hansen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2022 | $193,081 | Post-IPO | – | – | |
| Sep 2022 | $202,605 | Grant | – | – | |
| Jun 2021 | $521,395 | Grant | – | – | |
| Mar 2021 | $225,192 | Grant | – | – | |
| Jan 2021 | $364,871 | Grant | – | – | |
| Jan 2020 | $116,318 | Grant | – | – | |
| Feb 2019 | $4,905 | Grant | – | – | |
| Jan 2019 | Grant | – | – | ||
| Jan 2019 | $536,845 | Grant | – | – | |
| Sep 2018 | $345,722 | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Chr. Hansen
Chr. Hansen has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank, European Union and NAXS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed across the Nordic region. | 2007 | naxs.se | Stockholm, Sweden | |
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg | |
Private investment firm specializing in markets and partnerships. | ardian.com | |||
Private equity investments in market-leading companies across global sectors. | paipartners.com | |||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Chr. Hansen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Chr.Hansen (India) Private Limited (Chr. Hansen)
Chr.Hansen (India) Private Limited is the primary company behind Chr. Hansen. The board of Chr.Hansen (India) Private Limited currently have 2 directors; the longest-serving is Richa Kailashchandra Sharma, appointed in 2016. 13 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Richa Kailashchandra Sharma DIN 07509199 | Director | 09 May 2016 | 10 yrs 6 mo | Chr.Hansen (India) Private Limited |
| Anurag Chadha DIN 08940893 | Director | 29 Oct 2020 | 6 yrs | Chr.Hansen (India) Private Limited |
People of Chr. Hansen
626 people are tracked at Chr. Hansen (211 in leadership, 415 in team); the tracked headcount is 122.
| Name | Role | Group |
|---|---|---|
Ulrich Lund | Head Of P&o Core Delivery, Denmark | Leadership |
Gaëtan Mulliez | Sales Director / Business Manager France & Benelux | Leadership |
Pelle Clapp | Legal Business Partner Lead | Leadership |
Jens Erik Nielsen | Senior Vice President | Leadership |
Alejandro González | Head Of Software Development | Leadership |
Sowmya Shresth | Head Of People & Organization MEIA | Leadership |
Louise Christensen | Head Of Roskilde QC And LIMS Operations | Leadership |
Peter Eskild Jensen | Senior Director | Leadership |
Ditte Arltoft | Director, Global Product Safety | Leadership |
Dr. Eng. Klaus Pellicer Alborch | Senior CMO Specialist | Leadership |
Wynne Lewis | Head Of Service Excellence & Transformation | Leadership |
Mads Mourier | Director Global Regulatory Affairs, HHC & Industrial + Global Regulatory Advocacy | Leadership |
Jesper Deela Nielsen | Director, Global Procurement Head Of Logistics & Packaging | Leadership |
Timothy Wallace | Head, Scouting & Assessment, Ventures & External Innovation | Leadership |
Peter Steen Mortensen | Director, Head Of Public Affairs | Leadership |
Morten Anderskov | Head Of Digital Solutions & Development | Leadership |
Camila Lisboa Haiducki | Head Of Technical Services, Latam | Leadership |
Claus Crone Fuglsang | Chief Scientific Officer, Executive Vice President, Novonesis | Leadership |
Helge Christensen | Head Of Facility Service | Leadership |
Anita S. Christensen | Head Of Frozen And New Freezedried Packaging | Leadership |
606 more people are available in the full profile.
Complete people profiles for Chr. Hansen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Chr. Hansen
Chr. Hansen is a publicly listed company on the NASDAQ with ticker symbol CHR in USA, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Jun 2010
- Listed onNASDAQ: CHR
- Listed entityCheer Holding, Inc.
- Exchange sectorTechnology services
Financials of Chr. Hansen
Figures of Chr.Hansen (India) Private Limited, the primary company behind Chr. Hansen, for FY 2025. Revenue was ₹158 Cr (+22% year on year). Net profit was ₹6.80 Cr (4% margin). EBITDA was ₹11.88 Cr (8% margin). Revenue has grown at a compounded annual rate of +20% over three years and +17% over five years.
- ₹158 CrRevenue · FY 2025 · +22% YoY
- ₹6.80 CrNet profit · 4% margin
- ₹11.88 CrEBITDA · 8% margin
- ₹2.50 CrPaid-up capital
- +20%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Chr.Hansen (India) Private Limited are on its company page.
Detailed financial statements for Chr. Hansen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chr. Hansen
Chr. Hansen has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include ASTARTE Probiotics, Bovamine and GangaGen.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Colors, anthocyanins, and grape juice concentrates are manufactured in Spain. | secna.com | Chiva, Spain | 1961 | Apr 2021 | •••• | |
Provider of nutritional, pharmaceutical, cosmetic and medical applications product development & research services | jennewein-biotech.de | Rheinbreitbach, Germany | 2005 | Sep 2020 | $365.29M | |
Clinical research and probiotic fermentation services are provided. | uaslabs.com | Wausau, United States | 1979 | Jun 2020 | $530M | |
Probiotic supplements for women's vaginal health are provided. | astarte-probiotics.com | Vienna, Austria | 2007 | Apr 2020 | •••• | |
Office spaces are provided for rent in Tirol, Austria. | hundsbichler.com | Tirol, Austria | 1999 | Oct 2018 | •••• | |
Probiotics for livestock and poultry are manufactured by the company. | nutritionphysiologycompany.com | Guymon, United States | 1993 | Feb 2016 | $185M | |
Probiotic feed solutions for livestock are developed and marketed. | bovamine.com | Horsholm, Denmark | 2010 | Jan 2016 | $185M | |
Develop drugs for the prevention and treatment of bacterial infections that are resistant to antibiotics | gangagen.com | Bengaluru, India | 2000 | Dec 2009 | •••• |
Complete acquisition details for Chr. Hansen
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Chr. Hansen
13 dated milestones of Chr. Hansen across 179 years, from founding to its latest funding, stage changes and deals.
- Founded Chr. Hansen is founded.
- Exit Acquired by PAI Partners.
- Funding First funding round.
- Acquisition Acquires GangaGen.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Bovamine.
- Acquisition Acquires Nutrition Physiology Company.
- Acquisition Acquires Hundsbichler.
- Acquisition Acquires ASTARTE Probiotics.
- Acquisition Acquires UAS Labs.
- Acquisition Acquires Jennewein Biotechnologie.
- Acquisition Acquires Secna.
- Funding Latest funding round, Post-IPO, of $193K.
Web traffic of Chr. Hansen
The website of Chr. Hansen (chr-hansen.com) receives about 12.8K visits a month.
- Monthly visits12.8K
▲ 259.9% vs previous month
Websites whose visitors overlap most with Chr. Hansen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| danisco.com | 100% | View details | |||
| arla.com | 99% | 283.9K | #150,707 | View details | |
| sensientfoodcolors.com | 83% | View details | |||
| hjemmeriet.com | 81% | #1,237,918 | View details | ||
| kalsec.com | 78% | #1,530,765 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Chr. Hansen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Chr. Hansen
Complete news archive for Chr. Hansen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chr. Hansen
Chr. Hansen was founded in 1843 and raised its 1st funding round 162 years after it was founded.
Chr. Hansen is headquartered in Copenhagen, Denmark.
Chr. Hansen has 122 employees.
The primary company behind Chr. Hansen, Chr.Hansen (India) Private Limited, reported revenue of ₹158 Cr for FY 2025, up 22% year on year.
Developer of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. They develop products based on microbial strains. The food cultures enzymes division provides products such as cheese, meat, and plant fermented bases. Its Health and Nutrition division provides probiotic cultures for dietary supplements, over-the-counter pharmaceuticals, infant formula, animal feed, and plant protection industries. The companys Natural Colors division offers natural color solutions for the food industries, including the beverage, confectionery, ice cream, dairy, fruit preparation, and prepared food segments.
Yes, Chr. Hansen is publicly traded on NASDAQ under the ticker symbol CHR.
Chr. Hansen has made 8 acquisitions, including ASTARTE Probiotics, Bovamine, and GangaGen.
Chr. Hansen has 5 investors. Key investors include European Investment Bank, European Union, NAXS, Ardian, and PAI Partners.
Chr. Hansen operates through Chr.Hansen (India) Private Limited.
Yes. Chr. Hansen was acquired by PAI Partners in May 2005.
The legal entities of Chr. Hansen currently have 2 directors, including Anurag Chadha, Richa Kailashchandra Sharma.